Literature DB >> 21179311

Peripheral dose measurement in high-energy photon radiotherapy with the implementation of MOSFET.

Vassiliki Vlachopoulou1, Georgia Malatara, Harry Delis, Kiki Theodorou, Dimitrios Kardamakis, George Panayiotakis.   

Abstract

AIM: To study the peripheral dose (PD) from high-energy photon beams in radiotherapy using the metal oxide semiconductor field effect transistor (MOSFET) dose verification system.
METHODS: The radiation dose absorbed by the MOSFET detector was calculated taking into account the manufacturer's Correction Factor, the Calibration Factor and the threshold voltage shift. PD measurements were carried out for three different field sizes (5 cm × 5 cm, 10 cm × 10 cm and 15 cm × 15 cm) and for various depths with the source to surface distance set at 100 cm. Dose measurements were realized on the central axis and then at distances (1 to 18 cm) parallel to the edge of the field, and were expressed as the percentage PD (% PD) with respect to the maximum dose (d(max)). The accuracy of the results was evaluated with respect to a calibrated 0.3 cm(3) ionization chamber. The reproducibility was expressed in terms of standard deviation (s) and coefficient of variation.
RESULTS: % PD is higher near the phantom surface and drops to a minimum at the depth of d(max), and then tends to become constant with depth. Internal scatter radiation is the predominant source of PD and the depth dependence is determined by the attenuation of the primary photons. Closer to the field edge, where internal scatter from the phantom dominates, the % PD increases with depth because the ratio of the scatter to primary increases with depth. A few centimeters away from the field, where collimator scatter and leakage dominate, the % PD decreases with depth, due to attenuation by the water. The % PD decreases almost exponentially with the increase of distance from the field edge. The decrease of the % PD is more than 60% and can reach up to 90% as the measurement point departs from the edge of the field. For a given distance, the % PD is significantly higher for larger field sizes, due to the increase of the scattering volume. Finally, the measured PD obtained with MOSFET is higher than that obtained with an ionization chamber with percentage differences being from 0.6% to 34.0%. However, when normalized to the central d(max) this difference is less than 1%. The MOSFET system, in the early stage of its life, has a dose measurement reproducibility of within 1.8%, 2.7%, 8.9% and 13.6% for 22.8, 11.3, 3.5 and 1.3 cGy dose assessments, respectively. In the late stage of MOSFET life the corresponding values change to 1.5%, 4.8%, 11.1% and 29.9% for 21.8, 2.9, 1.6 and 1.0 cGy, respectively.
CONCLUSION: Comparative results acquired with the MOSFET and with an ionization chamber show fair agreement, supporting the suitability of this measurement for clinical in vivo dosimetry.

Entities:  

Keywords:  Dosimeter; Metal oxide semiconductor field effect transistor; Peripheral dose; Radiotherapy

Year:  2010        PMID: 21179311      PMCID: PMC3006482          DOI: 10.4329/wjr.v2.i11.434

Source DB:  PubMed          Journal:  World J Radiol        ISSN: 1949-8470


  27 in total

1.  A simple and generally applicable method to estimate the peripheral dose in radiation teletherapy with high energy x-rays or gamma radiation.

Authors:  P H Van der Giessen
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-07-15       Impact factor: 7.038

2.  Estimation of the radiation dose delivered to any point outside the target volume per patient treated with external beam radiotherapy.

Authors:  I Diallo; A Lamon; A Shamsaldin; E Grimaud; F de Vathaire; J Chavaudra
Journal:  Radiother Oncol       Date:  1996-03       Impact factor: 6.280

3.  Cancer induction by radiotherapy: dose dependence and spatial relationship to irradiated volume.

Authors:  Wolfgang Dörr; Thomas Herrmann
Journal:  J Radiol Prot       Date:  2002-09       Impact factor: 1.394

4.  Calculation of the dose delivered to organs outside the radiation beams.

Authors:  P Francois; C Beurtheret; A Dutreix
Journal:  Med Phys       Date:  1988 Nov-Dec       Impact factor: 4.071

5.  Calculation and measurement of the dose to points outside the primary beam for CO-60 gamma radiation.

Authors:  P H van der Giessen; C W Hurkmans
Journal:  Int J Radiat Oncol Biol Phys       Date:  1993-10-20       Impact factor: 7.038

6.  Calculation and measurement of the dose at points outside the primary beam for photon energies of 6, 10, and 23 MV.

Authors:  P H van der Giessen
Journal:  Int J Radiat Oncol Biol Phys       Date:  1994-12-01       Impact factor: 7.038

7.  Peripheral dose from megavolt beams.

Authors:  B A Fraass; J van de Geijn
Journal:  Med Phys       Date:  1983 Nov-Dec       Impact factor: 4.071

8.  MOSFET detectors in quality assurance of tomotherapy treatments.

Authors:  Amanda Cherpak; Ryan C N Studinski; Joanna E Cygler
Journal:  Radiother Oncol       Date:  2007-11-26       Impact factor: 6.280

9.  Estimating radiation-induced cancer risks at very low doses: rationale for using a linear no-threshold approach.

Authors:  David J Brenner; Rainer K Sachs
Journal:  Radiat Environ Biophys       Date:  2006-02-10       Impact factor: 1.925

10.  Cancer risks attributable to low doses of ionizing radiation: assessing what we really know.

Authors:  David J Brenner; Richard Doll; Dudley T Goodhead; Eric J Hall; Charles E Land; John B Little; Jay H Lubin; Dale L Preston; R Julian Preston; Jerome S Puskin; Elaine Ron; Rainer K Sachs; Jonathan M Samet; Richard B Setlow; Marco Zaider
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-10       Impact factor: 11.205

View more
  2 in total

1.  Peripheral doses in patients undergoing Cyberknife treatment for intracranial lesions. A single centre experience.

Authors:  Vassiliki Vlachopoulou; Christos Antypas; Harry Delis; Argyrios Tzouras; Nikolaos Salvaras; Dimitrios Kardamakis; George Panayiotakis
Journal:  Radiat Oncol       Date:  2011-11-14       Impact factor: 3.481

2.  Estimating and reducing dose received by cardiac devices for patients undergoing radiotherapy.

Authors:  Alexandra Bourgouin; Nicolas Varfalvy; Louis Archambault
Journal:  J Appl Clin Med Phys       Date:  2015-11-08       Impact factor: 2.102

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.